|
Add-on Therapy Improves Outcomes in Severe Asthma
Medscape May 5, 2011 — Omalizumab may provide additional relief for patients with severe allergic asthma who do not respond adequately to inhaled corticosteroids (ICS) or long-acting beta 2 -agonists (LABAs), investigators report in the May 3 issue of the … |
View full post on asthma – Google News